about
Risk of acute myocardial infarction after transurethral resection of prostate in elderlyOral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysisNatriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trialsTransradial approach for the endovascular treatment of type I endoleak after aortic aneurysm repair: a case report.Impact of an Innovative Educational Strategy on Medication Appropriate Use and Length of Stay in Elderly Patients.Myocardial β(2) -adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure.Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic studyGRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractility.β-adrenergic receptor responsiveness in aging heart and clinical implications.Negative impact of β-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms.Sudden onset of coma in a 70-year-old woman with cryoglobulinemia.GRK2 as a novel gene therapy target in heart failure.Coronary computed tomography: current role and future perspectives for cardiovascular risk stratification.Targeting the β-adrenergic receptor system through G-protein-coupled receptor kinase 2: a new paradigm for therapy and prognostic evaluation in heart failure: from bench to bedside.Instruments for geriatric assessment: new multidimensional assessment approaches.β-adrenergic receptors and G protein-coupled receptor kinase-2 in Alzheimer's disease: a new paradigm for prognosis and therapy?Molecular aspects of the cardioprotective effect of exercise in the elderly.Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis.Autonomic dysfunction in Alzheimer's disease: tools for assessment and review of the literature.Adrenal adrenoceptors in heart failure.β1-adrenergic receptor and sphingosine-1-phosphate receptor 1 (S1PR1) reciprocal downregulation influences cardiac hypertrophic response and progression to heart failure: protective role of S1PR1 cardiac gene therapyThe lipid theory in the pathogenesis of calcific aortic stenosis.The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance.Multicentre experience with MGuard net protective stent in ST-elevation myocardial infarction: safety, feasibility, and impact on myocardial reperfusion.Alterations of left ventricular deformation and cardiac sympathetic derangement in patients with systolic heart failure: a 3D speckle tracking echocardiography and cardiac ¹²³I-MIBG study.Impact of diabetes mellitus on lymphocyte GRK2 protein levels in patients with heart failure.Failure of protective effect of captopril and enalapril on exercise and dipyridamole-induced myocardial ischemia.Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure.Left ventricular hypertrophy reduction and clinical events. A meta-regression analysis of 14 studies in 12,809 hypertensive patients.Abciximab in elderly with acute coronary syndrome invasively treated: effect on outcome.A new approach to percutaneous coronary revascularization in patients requiring undeferrable non-cardiac surgery.Physical training increases eNOS vascular expression and activity and reduces restenosis after balloon angioplasty or arterial stenting in rats.Efficacy of transdermal nitroglycerin patches evaluated by dipyridamole-induced myocardial ischemia in patients with coronary artery disease. Comparison between continuous and intermittent schedule.An active lifestyle prior to coronary surgery is associated with improved survival in elderly patients.Effect of beta-adrenoceptor blockade on dipyridamole-induced myocardial asynergies in coronary artery disease.Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure.Aging exacerbates negative remodeling and impairs endothelial regeneration after balloon injury.Changes in serum uric acid levels and cardiovascular events: a meta-analysis.Angiotensin II-receptor antagonist losartan does not prevent nitroglycerin tolerance in patients with coronary artery disease.Percutaneous coronary intervention in a patient with acute non-ST-elevation myocardial infarction and haemophilia A: a 'genous' experience.
P50
Q26859700-D5A54A35-C682-4B58-9A54-2C33FC03251EQ28484769-5A95DE23-704E-4B1B-9419-8E32ECFC5E1EQ34614873-12BDCFA6-A52C-4F8B-AE4D-AD276D560591Q35051158-04923983-E94D-45FE-9112-9550A0DF2808Q36194529-FF1453D4-8F28-4CB3-A4E2-3DBCD7EB89EFQ36252791-5D804D56-2DA5-4968-B461-3E3814C03BC1Q37022630-EED1063F-A2AB-406A-976C-26B308D008F2Q37356016-371BB691-D563-4950-90B5-DA4AA6B4BBEDQ37453620-024D56CB-C66D-4227-ABB2-ACB53326CB42Q37470858-2C0CBB3D-7DA8-4412-9F4D-F624F7915FB7Q37568110-36410D5A-8106-48D9-BBF5-CE4D0D710856Q37783642-5C3D4691-E37F-42B9-84D4-B6EC6A50E6F3Q38004404-997528D6-AC53-415E-B11A-ED30E34AEC0AQ38010421-2BFD4BA2-0179-41C1-9C25-6B4BC5A48A78Q38019856-734B20B8-916B-4F22-AD3C-EA8616BA2820Q38064688-A4DF0977-4876-40B3-9D66-3D0CC9364EA7Q38129354-6CBD7989-C44A-4D28-8B3A-B9A522333464Q38203634-B6D9F31C-BF2C-4CC2-B27E-25B41543A0F2Q38217715-A74F43AF-42A4-4F65-957F-54B91D7031E2Q38234911-422951E1-AE4D-4F30-BDB3-867287B1FEAAQ38266154-78A2407E-B5F7-4224-ABC8-93621D3F2A49Q38393667-E638AF8D-78A8-4539-BE68-95B84CB0896BQ39822920-F4A6A6A4-FB56-441B-95CD-C3F6A1A7B72BQ39926234-888CEAF6-6584-43BD-818F-59D11B7AAC0EQ40968701-BA9EBE8E-4E6F-4981-A969-DF4289F61EFEQ41643288-A3359CAC-BBD0-4476-9F78-AA97B380A389Q42277108-B17E7E21-2B00-4E04-94F4-CEE63A21A86FQ43122865-E9D9D737-2519-434D-9AA0-E66F65B43B58Q43773726-F52AC720-FBEB-4765-94E3-8B1D2F2178FAQ44218909-ACFF4AAA-4419-4B9F-A679-D2F6DB60EC1BQ44233835-DF1BBB33-A1AE-4DED-B132-5AB01D023FB7Q44248162-B67A7D20-ED43-4CFD-A388-5D3F0B49A616Q44453450-16BE2C90-DA05-4480-8E23-6C1B6D314947Q44533171-A57C15BF-36BD-4794-8B7E-66AD99AFA19EQ44746669-FB864E1C-D524-47AB-845A-3EB40A7822CDQ44762347-45DA4918-1ECC-4F8E-88A5-010ADDCDFC2DQ44961822-BBABA220-EFAD-403D-BC84-D58097D2E02BQ45012331-9AE33366-3442-467E-BBC6-47825568EF71Q45270475-603B2B34-A0CA-4000-9642-77A9645CAB90Q45862010-95FA930E-EC25-41AD-B19E-79AA3A34B558
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Dario Leosco
@ast
Dario Leosco
@en
Dario Leosco
@es
Dario Leosco
@sl
type
label
Dario Leosco
@ast
Dario Leosco
@en
Dario Leosco
@es
Dario Leosco
@sl
prefLabel
Dario Leosco
@ast
Dario Leosco
@en
Dario Leosco
@es
Dario Leosco
@sl
P106
P1153
7003987300
P21
P31
P496
0000-0002-6543-5721